Levofloxacina Galenica Senese (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. By binding to their ATP‑binding sites, it prevents DNA strand separation, halting bacterial cell division and leading to rapid bacterial death across a broad spectrum of pathogens.

The specific dose and treatment duration are determined by the prescribing clinician based on the infection type, severity, patient age, weight, renal function, and other clinical factors. Healthcare professionals should follow local guidelines and the product label when prescribing.

Safety data for levofloxacin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician after careful assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Levofloxacin offers broad‑spectrum coverage against many Gram‑negative and Gram‑positive bacteria, including some resistant strains, and can be administered intravenously for rapid serum concentrations. Compared with beta‑lactams, it may be chosen when oral therapy is not feasible or when organisms are known to be resistant to other classes.

Levofloxacina Galenica Senese should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect from light, and avoid freezing or shaking the solution to maintain stability and potency.

The product is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically using a sterile infusion set, and the rate of infusion is set according to the prescribing information and patient-specific factors.

Serious adverse events include tendon rupture or inflammation, QT‑interval prolongation that can lead to arrhythmias, Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and central nervous system effects like seizures. Patients should be monitored closely for these rare but potentially life‑threatening reactions.

Levofloxacina Galenica Senese is contraindicated in patients with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. Caution is advised for individuals with a history of tendon disorders, significant cardiac arrhythmias, or those taking interacting medications.